The ESC Handbook on Cardiovascular Pharmacotherapy | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Juan Carlos Kaski
B01=Keld Per Kjeldsen
Category1=Non-Fiction
Category=GBC
Category=MJD
Category=MMG
COP=United Kingdom
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€50 to €100
PS=Active
SN=The European Society of Cardiology Series
softlaunch

The ESC Handbook on Cardiovascular Pharmacotherapy

English

This European Society of Cardiology (ESC) Handbook on Cardiovascular Pharmacotherapy has been developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy. Its recommendations are aligned with the ESC Clinical Practice Guidelines and based on the most recent scientific evidence in cardiovascular pharmacology and pharmacotherapy. The Handbook provides up-to-date information on pharmacotherapy for cardiovascular disease prevention, and treatment of cardiovascular disease, including ischaemic heart disease, heart failure, arrhythmias, and structural heart disease. The Handbook also deals with the important problems of cardiovascular pharmacotherapy in pregnancy and lactation, kidney insufficiency, and liver disease as well as focusing on major drug interactions, a topic of extreme importance in clinical practice. Two large sections of the book provide a comprehensive A-Z formulary of cardiac and non-cardiac pharmacological agents with practical and accessible information on the most important pharmacological aspects of these agents and their use in clinical practice. The Handbook represents essential reading for cardiologists, general practitioners, internal medicine specialists, anaesthetists, clinical pharmacologists, geriatricians, obstetricians, and cardiovascular nurse consultants. Junior doctors and trainees in all these specialties are also likely to find this book of help. The print edition comes with full access to the online version that will be updated at yearly intervals to keep it up to date. See more
Current price €65.69
Original price €72.99
Save 10%
Age Group_Uncategorizedautomatic-updateB01=Juan Carlos KaskiB01=Keld Per KjeldsenCategory1=Non-FictionCategory=GBCCategory=MJDCategory=MMGCOP=United KingdomDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€50 to €100PS=ActiveSN=The European Society of Cardiology Seriessoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 572g
  • Dimensions: 106 x 180mm
  • Publication Date: 23 May 2019
  • Publisher: Oxford University Press
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9780198759935

About

Professor Kaski is the Immediate Past Director of the Cardiovascular and Cell Sciences Research Institute St George's University of London. He is Doctor of Science University of London Fellow of the Royal College of physicians (London) the European Society of Cardiology the American College of Cardiology and the American Heart Association among over 20 other scientific societies worldwide. He is Deputy Editor in Chief International Journal of Cardiology Editor in Chief European Cardiology Review and the Cardiovascular Pharmacotherapy book series ISCP. Professor Kjeldsen is author of over 200 papers and multiple books. Presenter of over 100 lectures nationally and internationally he is Chairman at 45 scientific sessions. He has extensive experience as peer reviewer at scientific journals from editorial boards as chairman and organizer of meetings and congresses and as examiner of theses and research projects nationally and internationally. Teaching interests include Cardiology cardiovascular pharmacology and research methodology.

Customer Reviews

No reviews yet
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept